Industry News & Blogs
Msnbc.com Names Johns Hopkins Doctor One of 100 History Makers in the Making - 02/05/2010
Praised for her work, closing the racial gap in health care, Lisa Cooper, M.D., M.P.H., a professor of general internal medicine at the Johns Hopkins University School of Medicine, has been named one of "100 History Makers in the Making" by msnbc.com.
Powerful Myeloma Treatment Regimen Shows Promise for AL Amyloidosis
Hematology: The combination of bortezomib, cyclophosphamide, and dexamethasone (CyBorD, or CVD) is a recently discovered but already widely used MM treatment regimen that produces rapid and profound responses. Because of its success in MM, recent investigations have explored the use of this regimen
ZIOPHARM Oncology Inc Reports Positive Preliminary
NEW YORK, Feb. 13, 2012 -- ZIOPHARM Oncology, Inc. , a biopharmaceutical company with small molecule and synthetic biology approaches to new cancer
amednews: What's behind WellPoint's pay raise for primary care doctors? :: Feb. 13, 2012 ...
Hoping to save money by curtailing more expensive care, the health plan is offering an average of 10% more than current fee schedules.
NICE guidance on dasatinib, high-dose imatinib, and nilotinib for patients with CML who are
NICE guidance on dasatinib, high-dose imatinib, and nilotinib for patients with CML who are resistant or intolerant to imatinib. By - Scott Goulden, Frances Sutcliffe, Andrew Stevens
Laurel ENT and Allergy Opens New Location in Latrobe, PA | PRLog
Laurel ENT and Allergy Opens New Location in Latrobe, PA. Dr. Sumeet (Sam) Mathur, M.D, F.A.C.S and his staff announce the opening of a new location for Laurel ENT and Allergy in Latrobe, PA. - PR11795752
Salk discovery may lead to safer treatments for asthma, allergies and arthritis
Scientists have discovered a missing link between the body's biological clock and sugar metabolism system, a finding that may help avoid the serious side effects of drugs used for treating asthma, allergies and arthritis.
Integrated Hematology System offers customized configuration., Horiba Instruments,
HORIBA Medical-UK Launches HaemCell, Horiba Instruments, Inc.
Ziopharm Oncology, preclinical data, Darinaparsin, Hedgehog Signaling Pathway, Prostate Cancer,
Ziopharm Oncology announced that results from preclinical studies of darinaparsin (Zinapar or ZIO-101), a novel organic arsenic, in prostate cancer were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. In addition to company authors, the studies
Integrated Oncology Network, LLC ("ION") Announced That They Have Partnered with Prologics, LLC and
"We are excited by the opportunity to partner with the Prologics management team which is led by one of the top executives in the radiation oncology sector," said Jeffrey Goffman, chairman and CEO of ION, LLC. "This transaction coupled with our recent affiliation with Phillips
Refine by Topic:
Refine by Content Type:
Refine by Source:
- www.thelancet.com (5,991)
- download.thelancet.com (2,192)
- www.medpagetoday.com (350)
- www.prlog.org (122)
- www.em-consulte.com (58)
- www.prweb.com (55)
- www.australiandoctor.com.au (48)
- www.biospace.com (45)
- www.prleap.com (34)
- seekingalpha.com (33)
- www.fiercehealthcare.com (20)
- www.ama-assn.org (17)
